viral
acut
respiratori
infect
ari
associ
cluster
differenti
cd
cell
exhibit
diminish
product
cytokin
cytotox
molecul
though
cell
recogn
major
histocompat
complex
mhc
irestrict
viral
epitop
ex
vivo
stimul
cell
viral
peptid
fail
elicit
product
interferon
ifn
interleukin
il
tumor
necrosi
factor
tnf
degranul
measur
stain
featur
function
cell
uniqu
featur
viral
ari
tcell
dysfunct
occur
chronic
rather
acut
infect
mani
organ
although
regulatori
cell
treg
contribut
tcell
dysfunct
recent
work
varieti
virus
identifi
inhibitori
receptor
key
mediat
phenotyp
program
cell
death
wellstudi
inhibitori
receptor
tcell
impair
grow
evid
inhibitori
receptor
also
play
role
tendenc
cell
significantli
reduc
function
context
respiratori
viru
infect
term
cell
impair
tcell
immun
especi
cell
essenti
clear
acut
viral
lung
infect
mous
model
absenc
cell
lead
delay
clearanc
virus
wherea
human
defect
tcell
immun
associ
age
immun
suppress
cancer
tend
sever
infect
poorer
outcom
howev
despit
clear
need
tcellmedi
immun
infect
due
broad
rang
acut
virus
includ
influenza
viru
respiratori
syncyti
viru
rsv
pneumonia
viru
mice
vaccinia
viru
respiratori
system
infect
human
metapneumoviru
hmpv
other
associ
state
call
tcell
impair
broadli
defin
tcell
impair
occur
virusspecif
cell
fail
produc
inflammatori
cytokin
perform
cytotox
function
site
infect
virusspecif
cell
site
spleen
complet
function
fig
epitopespecif
cell
lungdrain
mediastin
lymph
node
complet
function
suggest
inflammatori
environ
lung
parenchyma
drive
process
tcell
impair
ari
tcell
impair
requir
cognat
antigen
cell
specif
viral
antigen
remain
function
primari
infect
also
appear
requir
activ
infect
dendrit
cell
vaccin
lead
function
virusspecif
cell
howev
adopt
transfer
cell
lung
caus
transfer
cell
lose
effector
potenti
though
infect
decreas
function
cell
indic
lung
environ
may
program
degre
suppress
even
set
without
infect
impair
also
occur
secondari
infect
may
indic
one
reason
human
poor
tcell
memori
respiratori
virus
suscept
reinfect
site
ga
exchang
lung
essenti
longterm
surviv
organ
left
uncheck
effector
cell
inflammatori
cytokin
immun
mediat
could
damag
healthi
tissu
alongsid
virusinfect
cell
inde
signific
portion
lung
injuri
seriou
infect
due
immunopatholog
rather
viru
infect
kill
cell
therefor
necessari
immun
system
balanc
viru
clearanc
immunemedi
damag
infect
tcell
impair
like
repres
host
mechan
protect
immunoregul
similarli
respiratori
viru
clear
normal
lung
homeostasi
must
restor
tcell
impair
like
repres
regulatori
mechan
restor
normal
state
reduc
function
surviv
cytotox
virusspecif
cell
strategi
revers
tcell
impair
discuss
associ
increas
immunopatholog
diseas
sever
delay
recoveri
weight
loss
time
point
viral
inocul
viru
almost
entir
clear
anoth
tissu
appear
favor
tcell
impair
brain
neurotrop
infect
jhm
strain
murin
coronaviru
caus
dysfunct
virusspecif
cell
consid
critic
delic
natur
neural
tissu
limit
heal
capac
brain
seem
like
tcell
impair
organ
repres
adapt
preserv
vital
organ
infect
recoveri
revers
tcell
dysfunct
neurotrop
infect
also
caus
increas
immunopatholog
diseas
sever
much
work
remain
fulli
elucid
mechan
impair
one
essenti
compon
action
inhibitori
receptor
welldescrib
inhibitori
receptor
interfer
signal
tcell
receptor
thu
far
reach
consequ
tcell
function
cytokin
releas
metabol
signal
alter
metabol
multipl
way
suppress
phosphatidylinositid
mtor
mammalian
target
rapamycin
activ
divert
metabol
pathway
away
glycolysi
toward
fatti
acid
oxid
increas
reactiv
oxygen
speci
promot
apoptosi
express
b
cell
well
occasion
antigenpres
cell
apc
two
ligand
express
almost
cell
type
express
apc
b
cell
upregul
antigen
stimul
inhibitori
ligand
induc
interferon
antigen
stimul
interferon
releas
tend
occur
simultan
site
infect
facilit
impair
specif
infect
tissu
explain
cell
spleen
lymph
node
impair
ari
blockad
genet
deplet
increas
function
virusspecif
cell
infect
hmpv
influenza
blockad
also
lead
faster
viru
clearanc
inhibitori
receptor
includ
upregul
respons
respiratori
viru
infect
appear
contribut
degre
tcell
impair
thu
far
appear
domin
inhibitori
receptor
ari
mediat
later
tcell
impair
blockad
increas
immunopatholog
without
reduc
viral
titer
although
inhibitori
receptor
discov
character
date
evalu
role
tcell
impair
viral
ari
although
mani
inhibitori
receptor
implic
impair
exhaust
two
state
differ
signific
way
tcell
exhaust
defin
antigenunrespons
cell
prolong
antigen
stimulu
chronic
infect
cancer
inhibitori
receptor
blockad
strategi
restor
tcell
function
licens
strategi
cancer
treatment
clinic
trial
chronic
infect
tcell
exhaust
well
character
use
lymphocyt
choriomening
viru
lcmv
model
chronic
infect
associ
progress
hierarch
loss
tcell
function
well
viru
persist
pulmonari
tcell
impair
also
associ
dysfunct
multipl
tcell
capac
tnf
granzym
b
product
degranul
measur
defect
viru
clearanc
howev
one
major
differ
tcell
impair
exhaust
time
tcell
exhaust
requir
longterm
antigen
exposur
inhibitori
receptor
becom
upregul
acut
lcmv
infect
associ
transient
express
wherea
chronic
lcmv
infect
lead
sustain
express
epitopespecif
cell
contrast
tcell
impair
seen
rel
earli
day
adapt
immun
respons
ari
express
remain
high
lung
lymphocyt
week
viru
clear
addit
tcell
exhaust
subset
exhaust
cell
rescu
blockad
remain
termin
differenti
unrespons
blockad
yet
known
whether
similar
subset
impair
cell
exist
lung
seem
like
particular
inflammatori
environ
pulmonari
tissu
trigger
cascad
upregul
rapidli
account
level
impair
day
acut
infect
microarray
bear
strike
similar
exhaust
day
chronic
lcmv
instanc
alveolar
macrophag
express
high
level
even
baselin
may
allow
lung
rapidli
trigger
impair
wherea
induct
apc
requir
infect
inflamm
import
consid
lung
tcell
impair
develop
vaccin
therapeut
respiratori
virus
well
anticip
potenti
side
effect
antibodi
checkpoint
blockad
therapi
cancer
licens
vaccin
mani
common
respiratori
virus
includ
rsv
hmpv
parainfluenza
virus
despit
extens
research
vaccin
elicit
tcell
immun
thought
enhanc
protect
respiratori
virus
whether
tcell
impair
contribut
failur
success
vaccin
develop
human
requir
studi
vaccin
adjuv
alum
induc
high
express
cell
mous
model
influenza
viruslik
particl
vaccin
mice
hmpv
protect
tcell
impair
inhibitori
receptor
express
secondari
challeng
tcell
impair
may
repres
barrier
vaccin
ari
pharmacolog
restor
tcell
function
detriment
effect
lung
well
rare
seriou
often
fatal
side
effect
checkpoint
inhibitor
pneumon
inflamm
lung
although
exact
mechan
establish
aberr
tcell
activ
self
foreign
antigen
lung
may
contribut
human
receiv
checkpoint
inhibit
therapi
acquir
common
respiratori
viral
infect
may
increas
risk
pneumon
futur
improv
checkpoint
therapi
would
abil
specif
target
tumorspecif
cell
moreov
studi
respiratori
viru
infect
patient
treat
checkpoint
inhibitor
would
help
us
understand
anticip
potenti
risk
associ
treatment
tcell
impair
mediat
inhibitori
receptor
repres
regulatori
adapt
immun
system
preserv
healthi
lung
tissu
acut
viral
infect
though
antibodi
blockad
strategi
revers
tcell
impair
offer
excit
treatment
cancer
use
drug
pose
risk
lung
function
therefor
warrant
studi
pulmonari
tcell
impair
contribut
memori
vaccin
respons
though
ramif
interact
yet
clear
find
perfect
balanc
immunoprotect
immunopatholog
remain
elus
